Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A drug that mimics the female hormone ...

Scientists are developing magnetically driven nanorobots that can actively navigate the bloodstream and deliver chemotherapy ...

William Blair starts coverage on Compass Therapeutics, saying its lead drug could reshape bile duct cancer treatment and ...

Gilead Sciences has found a shiny new package for one of its cancer assets, inking a research pact worth up to $300 million ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.